Yasodha Natkunam

22.4k total citations · 2 hit papers
238 papers, 8.8k citations indexed

About

Yasodha Natkunam is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Yasodha Natkunam has authored 238 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Pathology and Forensic Medicine, 119 papers in Oncology and 60 papers in Immunology. Recurrent topics in Yasodha Natkunam's work include Lymphoma Diagnosis and Treatment (168 papers), Viral-associated cancers and disorders (68 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Yasodha Natkunam is often cited by papers focused on Lymphoma Diagnosis and Treatment (168 papers), Viral-associated cancers and disorders (68 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Yasodha Natkunam collaborates with scholars based in United States, United Kingdom and Canada. Yasodha Natkunam's co-authors include Roger A. Warnke, Shuchun Zhao, Izidore S. Lossos, Ranjana H. Advani, Ronald Levy, Richard T. Hoppe, Matt van de Rijn, Daphne de Jong, Robert Tibshirani and Kelli Montgomery and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Yasodha Natkunam

230 papers receiving 8.7k citations

Hit Papers

Multiplexed ion beam imaging of human breast tumors 2014 2026 2018 2022 2014 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multiplexed ion beam imaging of human breast tumors
    2014 784 citations Shuchun Zhao, Yasodha Natkunam et al. profile →
  2. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
    2016 555 citations Margaretha G.M. Roemer, Ranjana H. Advani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasodha Natkunam United States 50 4.5k 4.4k 2.3k 2.1k 1.4k 238 8.8k
Wing C. Chan United States 51 5.7k 1.3× 3.9k 0.9× 2.5k 1.1× 2.2k 1.0× 2.6k 1.8× 261 9.3k
Ioannis Anagnostopoulos Germany 44 3.3k 0.7× 3.4k 0.8× 1.4k 0.6× 2.3k 1.1× 1.1k 0.8× 136 7.8k
Izidore S. Lossos United States 53 5.8k 1.3× 4.3k 1.0× 2.9k 1.2× 2.8k 1.3× 2.5k 1.8× 353 10.8k
Jan Delabie Norway 48 4.7k 1.0× 3.2k 0.7× 1.4k 0.6× 1.7k 0.8× 1.9k 1.3× 201 7.0k
Teresa Marafioti United Kingdom 39 3.0k 0.7× 3.3k 0.8× 1.4k 0.6× 1.9k 0.9× 1.1k 0.7× 167 6.6k
Martin‐Leo Hansmann Germany 51 6.9k 1.5× 5.0k 1.1× 2.1k 0.9× 3.1k 1.5× 2.8k 1.9× 247 10.8k
Luc Xerri France 45 3.4k 0.7× 4.6k 1.1× 2.8k 1.2× 2.4k 1.1× 1.3k 0.9× 172 9.0k
Eric D. Hsi United States 62 6.0k 1.3× 4.7k 1.1× 3.2k 1.4× 2.6k 1.2× 3.5k 2.4× 405 12.2k
Daphne de Jong Netherlands 54 5.8k 1.3× 4.4k 1.0× 1.9k 0.8× 1.7k 0.8× 2.0k 1.4× 214 10.3k
Harald Stein Germany 48 4.9k 1.1× 3.3k 0.8× 1.3k 0.6× 2.5k 1.2× 1.6k 1.1× 117 8.4k

Countries citing papers authored by Yasodha Natkunam

Since Specialization
Citations

This map shows the geographic impact of Yasodha Natkunam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasodha Natkunam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasodha Natkunam more than expected).

Fields of papers citing papers by Yasodha Natkunam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasodha Natkunam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasodha Natkunam. The network helps show where Yasodha Natkunam may publish in the future.

Co-authorship network of co-authors of Yasodha Natkunam

This figure shows the co-authorship network connecting the top 25 collaborators of Yasodha Natkunam. A scholar is included among the top collaborators of Yasodha Natkunam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasodha Natkunam. Yasodha Natkunam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulterys, Philip L., Sebastian Fernandez‐Pol, Sheren Younes, et al.. (2025). Expression of CD47 protein in hematolymphoid neoplasms: Implications for CD47-mediated cancer immunotherapy. American Journal of Clinical Pathology. 163(6). 883–897.
2.
3.
4.
Khan, Anum, et al.. (2024). Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma. Blood Cancer Journal. 14(1). 92–92. 2 indexed citations
5.
Younes, Sheren, Shuchun Zhao, Robbie G. Majzner, et al.. (2023). Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance. Modern Pathology. 36(10). 100256–100256. 10 indexed citations
6.
Schroers‐Martin, Joseph G., Joanne Soo, Florian Scherer, et al.. (2023). Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors. Cancer Discovery. 13(6). 1310–1323. 23 indexed citations
7.
Steen, Chloé B., Bogdan Luca, Mohammad Shahrokh Esfahani, et al.. (2021). The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 39(10). 1422–1437.e10. 149 indexed citations
8.
Balassanian, Ronald, Matthew C. Cheung, Lorenzo Falchi, et al.. (2021). Global Cytopathology-Hematopathology Practice Trends. American Journal of Clinical Pathology. 157(2). 196–201. 2 indexed citations
9.
Hossain, Nasheed, Bita Sahaf, Jay Y. Spiegel, et al.. (2018). Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies. Blood. 132(Supplement 1). 490–490. 48 indexed citations
10.
Satpathy, Ansuman T., Ryanne A. Brown, Carlos G. Briseño, et al.. (2018). Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin. Modern Pathology. 31(9). 1479–1486. 12 indexed citations
11.
Wernig, Gerlinde, Shih‐Yu Chen, Lu Cui, et al.. (2017). Unifying mechanism for different fibrotic diseases. Proceedings of the National Academy of Sciences. 114(18). 4757–4762. 145 indexed citations
12.
Schroers‐Martin, Joseph G., Florian Scherer, Joanne Soo, et al.. (2017). Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis. Blood. 130. 308–308. 1 indexed citations
13.
14.
Roemer, Margaretha G.M., Ranjana H. Advani, Robert Redd, et al.. (2016). Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status. Cancer Immunology Research. 4(11). 910–916. 139 indexed citations
15.
Metcalf, Ryan A., Ahmad Monabati, Monika Vyas, et al.. (2014). Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma. Human Pathology. 45(8). 1730–1736. 28 indexed citations
16.
Alencar, Alvaro J., Raquel Malumbres, Ranjana H. Advani, et al.. (2011). MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP. Clinical Cancer Research. 17(12). 4125–4135. 113 indexed citations
17.
Dai, Bojie, X. Frank Zhao, Patrick R. Hagner, et al.. (2009). Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma. Cancer Research. 69(19). 7835–7843. 23 indexed citations
18.
Malumbres, Raquel, Jun Chen, Rob Tibshirani, et al.. (2008). Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Blood. 111(12). 5509–5514. 73 indexed citations
19.
Snow, Andrew L., Stacie Lambert, Yasodha Natkunam, et al.. (2006). EBV Can Protect Latently Infected B Cell Lymphomas from Death Receptor-Induced Apoptosis. The Journal of Immunology. 177(5). 3283–3293. 34 indexed citations
20.
Natkunam, Yasodha, Kojo S.J. Elenitoba‐Johnson, Douglas W. Kingma, & Onsi W. Kamel. (1997). Epstein‐Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. Arthritis & Rheumatism. 40(6). 1152–1156. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wing C. Chan Breakdown of academic impact, for papers by Ioannis Anagnostopoulos Breakdown of academic impact, for papers by Izidore S. Lossos Breakdown of academic impact, for papers by Jan Delabie Breakdown of academic impact, for papers by Teresa Marafioti Breakdown of academic impact, for papers by Martin‐Leo Hansmann Breakdown of academic impact, for papers by Luc Xerri Breakdown of academic impact, for papers by Eric D. Hsi Breakdown of academic impact, for papers by Daphne de Jong Breakdown of academic impact, for papers by Harald Stein
Rankless by CCL
2026